The fate is not always written in the genes: Epigenomics in epidemiologic studies

Environmental and Molecular Mutagenesis

Volumn 54, Issue 7, 2013, Pages 533-541

  Langevin, Scott M ^a   Kelsey, Karl T ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

DNA methylation; EWAS; Molecular epidemiology

Indexed keywords

CARCINOGENESIS; CASE CONTROL STUDY; CELL DIFFERENTIATION; COST EFFECTIVENESS ANALYSIS; DNA METHYLATION; EPIGENETICS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MOLECULAR EPIDEMIOLOGY; PROMOTER REGION; REVIEW; SOMATIC CELL; TISSUE DIFFERENTIATION;

DNA METHYLATION; EWAS; MOLECULAR EPIDEMIOLOGY;

AGING; DNA METHYLATION; EPIGENESIS, GENETIC; GENOMICS; HUMANS; MOLECULAR EPIDEMIOLOGY;

EID: 84882276110     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.21762     Document Type: Review

References (73)

1. Accomando WP, Wiencke JK, Houseman EA, Butler RA, Zheng S, Nelson HH, Kelsey KT. 2012. Decreased NK cells in patients with head and neck cancer determined in archival DNA. Clin Cancer Res 18:6147-6154.
2. Anderson OS, Sant KE, Dolinoy DC. 2012. Nutrition and epigenetics: An interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. J Nutr Biochem 23:853-859.
3. Ballestar E. 2010. Epigenetics lessons from twins: Prospects for autoimmune disease. Clin Rev Allergy Immunol 39:30-41.
4. Baylin SB, Jones PA. 2011. A decade of exploring the cancer epigenome-Biological and translational implications. Nat Rev Cancer 11:726-734.
5. Bell JT, Spector TD. 2011. A twin approach to unraveling epigenetics. Trends Genet 27:116-125.
6. Bell JT, Tsai PC, Yang TP, Pidsley R, Nisbet J, Glass D, Mangino M, Zhai G, Zhang F, Valdes A, Shin SY, Dempster EL, Murray RM, Grundberg E, Hedman AK, Nica A, Small KS, Dermitzakis ET, McCarthy MI, Mill J, Spector TD, Deloukas P. 2012. Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet 8:e1002629.
7. Bock C. 2012. Analysing and interpreting DNA methylation data. Nat Rev Genet 13:705-719.
8. Brennan K, Flanagan JM. 2012. Epigenetic epidemiology for cancer risk: harnessing germline epigenetic variation. Methods Mol Biol 863:439-465.
9. Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y. 2010. Epigenetics and autoimmunity. J Autoimmun 34:J207-J219.
10. Calkins K, Devaskar SU. 2011. Fetal origins of adult disease. Curr Probl Pediatr Adolesc Health Care 41:158-176.
11. Calvanese V, Lara E, Kahn A, Fraga MF. 2009. The role of epigenetics in aging and age-related diseases. Ageing Res Rev 8:268-276.
12. Cheng CK, Chan J, Cembrowski GS, van Assendelft OW. 2004. Complete blood count reference interval diagrams derived from NHANES III: stratification by age, sex, and race. Lab Hematol 10:42-53.
13. Choudhuri S, Cui Y, Klaassen CD. 2010. Molecular targets of epigenetic regulation and effectors of environmental influences. Toxicol Appl Pharmacol 245:378-393.
14. Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, Wiemels JL, Nelson HH, Karagas MR, Padbury JF, Bueno R, Sugarbaker DJ, Yeh RF, Wiencke JK, Kelsey KT. 2009. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 5:e1000602.
15. Christensen BC, Marsit CJ. 2011. Epigenomics in environmental health. Front Genet 2:84.
16. Cowley AW, Jr., Nadeau JH, Baccarelli A, Berecek K, Fornage M, Gibbons GH, Harrison DG, Liang M, Nathanielsz PW, O'Connor DT, Ordovas J, Peng W, Soares MB, Szyf M, Tolunay HE, Wood KC, Zhao K, Galis ZS. 2012. Report of the national heart, lung, and blood institute working group on epigenetics and hypertension. Hypertension 59:899-905.
17. Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, Herb B, Ladd-Acosta C, Rho J, Loewer S, Miller J, Schlaeger T, Daley GQ, Feinberg AP. 2009. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 41:1350-1353.
18. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, Burton J, Cox TV, Davies R, Down TA, Haefliger C, Horton R, Howe K, Jackson DK, Kunde J, Koenig C, Liddle J, Niblett D, Otto T, Pettett R, Seemann S, Thompson C, West T, Rogers J, Olek A, Berlin K, Beck S. 2006. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 38:1378-1385.
19. Ehrlich M. 2002. DNA hypomethylation, cancer, the immunodeficiency, centromeric region instability, facial anomalies syndrome and chromosomal rearrangements. J Nutr 132:2424S-2429S.
20. Esteller M. 2008. Epigenetics in cancer. N Engl J Med 358:1148-1159.
21. Fazzari MJ, Greally JM. 2010. Introduction to epigenomics and epigenome-wide analysis. Methods Mol Biol 620:243-265.
22. Feber A, Wilson GA, Zhang L, Presneau N, Idowu B, Down TA, Rakyan VK, Noon LA, Lloyd AC, Stupka E, Schiza V, Teschendorff AE, Schroth GP, Flanagan A, Beck S. 2011. Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors. Genome Res 21:515-524.
23. Federico A, D'Aiuto E, Borriello F, Barra G, Gravina AG, Romano M, De Palma R. 2010. Fat: A matter of disturbance for the immune system. World J Gastroenterol 16:4762-4772.
24. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, Heine-Suner D, Cigudosa JC, Urioste M, Benitez J, Boix-Chornet M, Sanchez-Aguilera A, Ling C, Carlsson E, Poulsen P, Vaag A, Stephan Z, Spector TD, Wu YZ, Plass C, Esteller M. 2005. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 102:10604-10609.
25. Fukushima T, Takeshima H, Kataoka H. 2009. Anti-glioma therapy with temozolomide and status of the DNA-repair gene MGMT. Anticancer Res 29:4845-4854.
26. Gluckman PD, Hanson MA, Low FM. 2011. The role of developmental plasticity and epigenetics in human health. Birth Defects Res C Embryo Today 93:12-18.
27. Handel AE, Ramagopalan SV. 2010. Is Lamarckian evolution relevant to medicine? BMC Med Genet 11:73.
28. Hasler R, Feng Z, Backdahl L, Spehlmann ME, Franke A, Teschendorff A, Rakyan VK, Down TA, Wilson GA, Feber A, Beck S, Schreiber S, Rosenstiel P. 2012. A functional methylome map of ulcerative colitis. Genome Res 22:2130-2137.
29. Hesson LB, Hitchins MP, Ward RL. 2010. Epimutations and cancer predisposition: Importance and mechanisms. Curr Opin Genet Dev 20:290-298.
30. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. 2009. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 106:9362-9367.
31. Hitchins MP. 2010. Inheritance of epigenetic aberrations (constitutional epimutations) in cancer susceptibility. Adv Genet 70:201-243.
32. Hoffmann MJ, Schulz WA. 2005. Causes and consequences of DNA hypomethylation in human cancer. Biochem Cell Biol 83:296-321.
33. Holliday R, Pugh JE. 1975. DNA modification mechanisms and gene activity during development. Science 187:226-232.
34. Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, Wiencke JK, Kelsey KT. 2012. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 13:86.
35. Igarashi J, Muroi S, Kawashima H, Wang X, Shinojima Y, Kitamura E, Oinuma T, Nemoto N, Song F, Ghosh S, Held WA, Nagase H. 2008. Quantitative analysis of human tissue-specific differences in methylation. Biochem Biophys Res Commun 376:658-664.
36. Illingworth R, Kerr A, Desousa D, Jorgensen H, Ellis P, Stalker J, Jackson D, Clee C, Plumb R, Rogers J, Humphray S, Cox T, Langford C, Bird A. 2008. A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol 6:e22.
37. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, Ji H, Potash JB, Sabunciyan S, Feinberg AP. 2009. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 41:178-186.
38. Issa JP, Garber JE. 2011. Time to think outside the (genetic) box. Cancer Prev Res (Phila) 4:6-8.
39. Jayaraman S. 2011. Epigenetics of autoimmune diabetes. Epigenomics 3:639-648.
40. Joubert BR, Haberg SE, Nilsen RM, Wang X, Vollset SE, Murphy SK, Huang Z, Hoyo C, Midttun O, Cupul-Uicab LA, Ueland PM, Wu MC, Nystad W, Bell DA, Peddada SD, London SJ. 2012. 450K epigenome-wide scan identifies differential DNA methylation in newborns related to maternal smoking during pregnancy. Environ Health Perspect 120:1425-1431.
41. Kiecolt-Glaser JK, Gouin JP, Hantsoo L. 2010. Close relationships, inflammation, and health. Neurosci Biobehav Rev 35:33-38.
42. Koestler DC, Marsit CJ, Christensen BC, Accomando W, Langevin SM, Houseman EA, Nelson HH, Karagas MR, Wiencke JK, Kelsey KT. 2012. Peripheral blood immune cell methylation profiles are associated with nonhematopoietic cancers. Cancer Epidemiol Biomarkers Prev 21:1293-1302.
43. Kulis M, Esteller M. 2010. DNA methylation and cancer. Adv Genet 70:27-56.
44. Lander ES. 2011. Initial impact of the sequencing of the human genome. Nature 470:187-197.
45. Ligtenberg MJ, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M, Lee TY, Bodmer D, Hoenselaar E, Hendriks-Cornelissen SJ, Tsui WY, Kong CK, Brunner HG, van Kessel AG, Yuen ST, van Krieken JH, Leung SY, Hoogerbrugge N. 2009. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. Nat Genet 41:112-117.
46. Lim U, Song MA. 2012. Dietary and lifestyle factors of DNA methylation. Methods Mol Biol 863:359-376.
47. Marsit CJ, Koestler DC, Christensen BC, Karagas MR, Houseman EA, Kelsey KT. 2011. DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer. J Clin Oncol 29:1133-1139.
48. Meaburn E, Schulz R. 2012. Next generation sequencing in epigenetics: Insights and challenges. Semin Cell Dev Biol 23:192-199.
49. Mehta H, Nazzal K, Sadikot RT. 2008. Cigarette smoking and innate immunity. Inflamm Res 57:497-503.
50. Milosavljevic A. 2011. Emerging patterns of epigenomic variation. Trends Genet 27:242-250.
51. Miranda TB, Jones PA. 2007. DNA methylation: The nuts and bolts of repression. J Cell Physiol 213:384-390.
52. Oertelt-Prigione S. 2012. The influence of sex and gender on the immune response. Autoimmun Rev 11(6-7):A479-A485.
53. Ohgane J, Yagi S, Shiota K. 2008. Epigenetics: The DNA methylation profile of tissue-dependent and differentially methylated regions in cells. Placenta 29 Suppl A:S29-S35.
54. Ordovas JM, Smith CE. 2010. Epigenetics and cardiovascular disease. Nat Rev Cardiol 7:510-519.
55. Petronis A. 2006. Epigenetics and twins: Three variations on the theme. Trends Genet 22:347-350.
56. Qureshi IA, Mehler MF. 2011. Advances in epigenetics and epigenomics for neurodegenerative diseases. Curr Neurol Neurosci Rep 11:464-473.
57. Rakyan VK, Beyan H, Down TA, Hawa MI, Maslau S, Aden D, Daunay A, Busato F, Mein CA, Manfras B, Dias KR, Bell CG, Tost J, Boehm BO, Beck S, Leslie RD. 2011a. Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet 7:e1002300.
58. Rakyan VK, Down TA, Balding DJ, Beck S. 2011b. Epigenome-wide association studies for common human diseases. Nat Rev Genet 12:529-541.
59. Rakyan VK, Down TA, Thorne NP, Flicek P, Kulesha E, Graf S, Tomazou EM, Backdahl L, Johnson N, Herberth M, Howe KL, Jackson DK, Miretti MM, Fiegler H, Marioni JC, Birney E, Hubbard TJ, Carter NP, Tavare S, Beck S. 2008. An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res 18:1518-1529.
60. Reinius LE, Acevedo N, Joerink M, Pershagen G, Dahlen SE, Greco D, Soderhall C, Scheynius A, Kere J. 2012. Differential DNA methylation in purified human blood cells: Implications for cell lineage and studies on disease susceptibility. PLoS One 7:e41361.
61. Rivera RM, Bennett LB. 2010. Epigenetics in humans: An overview. Curr Opin Endocrinol Diabetes Obes 17:493-499.
62. Schilling E, Rehli M. 2007. Global, comparative analysis of tissue-specific promoter CpG methylation. Genomics 90:314-323.
63. Shenker NS, Polidoro S, van Veldhoven K, Sacerdote C, Ricceri F, Birrell MA, Belvisi MG, Brown R, Vineis P, Flanagan JM. 2013. Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking. Hum Mol Genet 22:843-851.
64. Slomko H, Heo HJ, Einstein FH. 2012. Minireview: Epigenetics of obesity and diabetes in humans. Endocrinology 153:1025-1030.
65. Stadler ZK, Vijai J, Thom P, Kirchhoff T, Hansen NA, Kauff ND, Robson M, Offit K. 2010. Genome-wide association studies of cancer predisposition. Hematol Oncol Clin North Am 24:973-996.
66. Szabo G, Mandrekar P. 2009. A recent perspective on alcohol, immunity, and host defense. Alcohol Clin Exp Res 33:220-232.
67. Terry MB, Delgado-Cruzata L, Vin-Raviv N, Wu HC, Santella RM. 2011. DNA methylation in white blood cells: Association with risk factors in epidemiologic studies. Epigenetics 6:828-837.
68. Thirlwell C, Eymard M, Feber A, Teschendorff A, Pearce K, Lechner M, Widschwendter M, Beck S. 2010. Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip. Methods 52:248-254.
69. Tost J. 2010. DNA methylation: An introduction to the biology and the disease-associated changes of a promising biomarker. Mol Biotechnol 44:71-81.
70. Waddington CH. 1942. The epigenotype. Endeavour 1:18-20.
71. Wiencke JK, Accomando WP, Zheng S, Patoka J, Dou X, Phillips JJ, Hsuang G, Christensen BC, Houseman EA, Koestler DC, Bracci P, Wiemels JL, Wrensch M, Nelson HH, Kelsey KT. 2012. Epigenetic biomarkers of T-cells in human glioma. Epigenetics 7:12.
72. Wilson AS, Power BE, Molloy PL. 2007. DNA hypomethylation and human diseases. Biochim Biophys Acta 1775:138-162.
73. Zhao Q, Zhang Y. 2011. Epigenome sequencing comes of age in development, differentiation and disease mechanism research. Epigenomics 3:207-220.